SHARE
COPY LINK

HEALTH

Family warns of painkiller risk after Irishman dies on holiday

Relatives of an Irishman who died after being prescribed a common painkiller in Spain have spoken out to warn other holidaymakers of the danger.

Family warns of painkiller risk after Irishman dies on holiday
Billy Smyth died after taking the painkiller Nolotil. File photo: AFP

William “Billy” Smyth from Mullingar in Ireland was prescribed a course of the painkiller Nolotil by a Spanish doctor to treat a shoulder pain while on holiday in Torrevieja in February.

Several months later after suffering persistent cold-like symptoms it was discovered that the drug had caused toxic poisoning in his bone marrow.

“He couldn’t shake a common cold and the sore throat he had. The GP checked him out and found his white blood cell count was very low and called an ambulance to take him to emergency straight away,” Smyth’s son Derek told Independent.ie.

The low white cell count led to Smyth developing sepsis and necrotising fasciitis and he underwent emergency surgery in an attempt to remove the affected tissue.

“My father remained in a coma following surgery. He developed multiple organ failure, received a colostomy, kidney dialysis and many life saving measures but on April 17th my father died from septic shock due to the complications developed from taking Nolotil,” said Smyth's son.

The family have now gone public in the belief that other visitors may be in danger if prescribed a drug which is banned in the UK and Ireland and which is known to have a high risk of causing agranulocytosis (lowered white blood cell count).

“We’re obviously upset that the drug was prescribed to him but at the end of the day, the drug is legal in certain countries,” he warned.

“Irish people should be cautious and think twice about what they’re taking. If they even stop for a couple of seconds and think, they could save their lives.”

The Nolotil drug is a brand name for Metamizole, an anti-inflammatory drug used for the treatment of mild pain.

While the drug is available on prescription in Spain, it has never been licensed in the UK, Ireland or the USA. 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

HEALTH

Lengthy waiting times at Danish hospitals not going away yet: minister

Danish Minister for the Interior and Health Sophie Løhde has warned that, despite increasing activity at hospitals, it will be some time before current waiting lists are reduced.

Lengthy waiting times at Danish hospitals not going away yet: minister

The message comes as Løhde was set to meet with officials from regional health authorities on Wednesday to discuss the progress of an acute plan for the Danish health system, launched at the end of last year in an effort to reduce a backlog of waiting times which built up during the coronavirus crisis.

An agreement with regional health authorities on an “acute” spending plan to address the most serious challenges faced by the health services agreed in February, providing 2 billion kroner by the end of 2024.

READ ALSO: What exactly is wrong with the Danish health system?

The national organisation for the health authorities, Danske Regioner, said to newspaper Jyllands-Posten earlier this week that progress on clearing the waiting lists was ahead of schedule.

Some 245,300 operations were completed in the first quarter of this year, 10 percent more than in the same period in 2022 and over the agreed number.

Løhde said that the figures show measures from the acute plan are “beginning to work”.

“It’s positive but even though it suggests that the trend is going the right way, we’re far from our goal and it’s important to keep it up so that we get there,” she said.

“I certainly won’t be satisfied until waiting times are brought down,” she said.

“As long as we are in the process of doing postponed operations, we will unfortunately continue to see a further increase [in waiting times],” Løhde said.

“That’s why it’s crucial that we retain a high activity this year and in 2024,” she added.

Although the government set aside 2 billion kroner in total for the plan, the regional authorities expect the portion of that to be spent in 2023 to run out by the end of the summer. They have therefore asked for some of the 2024 spending to be brought forward.

Løhde is so far reluctant to meet that request according to Jyllands-Posten.

SHOW COMMENTS